Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$409K Buy
23,537
+15,284
+185% +$289K 0.05% 466
2025
Q4
$155K Buy
+8,253
New +$138K 0.02% 1119
2025
Q1
Sell
-4,228
Closed -$90.5K 1669
2024
Q4
$90.5K Buy
+4,228
New +$103K 0.01% 1224
2024
Q2
Sell
-19,912
Closed -$211K 1689
2024
Q1
$211K Buy
19,912
+9,489
+91% +$94.9K 0.04% 568
2023
Q4
$125K Sell
10,423
-1,049
-9% -$8.59K 0.02% 850
2023
Q3
$80.3K Buy
11,472
+1,527
+15% +$14.1K 0.02% 1013
2023
Q2
$84.5K Buy
9,945
+7,518
+310% +$62.7K 0.02% 926
2023
Q1
$22.2K Buy
+2,427
New +$31K 0.01% 1403
2022
Q4
Sell
-2,132
Closed -$36K 1589
2022
Q3
$36K Buy
+2,132
New +$45.8K 0.02% 1130

Other funds holding CDNA

State of Wyoming's CDNA Position: Q1 2026 in Review

State of Wyoming increased its CareDx (CDNA) stake by 185% in Q1 2026, buying an estimated $289K and bringing the position to 23,537 shares worth $409K. The position accounts for 0.05% of the portfolio, ranked #466.

State of Wyoming first reported a position in CDNA in Q3 2022 and has held it in 9 quarters since. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • State of Wyoming held 23,537 shares of CareDx worth $409K as of Q1 2026.
  • State of Wyoming bought 15,284 CareDx shares in Q1 2026, an estimated $289K.
  • CareDx made up 0.05% of State of Wyoming's portfolio in Q1 2026, its #466 holding.
  • State of Wyoming first reported a position in CareDx in Q3 2022 and has held it in 9 quarters since.
  • 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.